Stem cells as a new treatment for peripheral artery disease: Hype or hope? the point of view of a vascular surgeon

Bio-Medical Materials and Engineering

Volumn 25, Issue , 2015, Pages S73-S78

  Lehalle, Bertrand ^a,b  

^a Pôle Vaisseaux Vascular Center   (France)

^b Department of Cardiology   (France)

Author keywords

Cell therapy; critical limb ischemia; mesenchymal stem cells; peripheral artery disease

Indexed keywords

CELL CULTURE; DISEASE CONTROL; PATIENT TREATMENT; STEM CELLS;

CELL THERAPY; CRITICAL LIMB ISCHEMIA; MESENCHYMAL STEM CELL; PERIPHERAL ARTERIAL DISEASE; PERIPHERAL ARTERY DISEASE; REVASCULARIZATION; STEM CELL THERAPY; VASCULAR SURGEONS;

DISEASES;

ANGIOGENESIS; ARTERITIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW DERIVED MONONUCLEAR CELL; CONFERENCE PAPER; CRITICAL LIMB ISCHEMIA; ENDOTHELIAL PROGENITOR CELL; HUMAN; LIMB AMPUTATION; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVASCULARIZATION; STEM CELL TRANSPLANTATION; VASCULAR SURGEON; EVIDENCE BASED MEDICINE; ISCHEMIA; LEG; PERIPHERAL ARTERIAL DISEASE; PROCEDURES; TREATMENT OUTCOME; TRENDS; VASCULARIZATION;

EVIDENCE-BASED MEDICINE; HUMANS; ISCHEMIA; LOWER EXTREMITY; PERIPHERAL ARTERIAL DISEASE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84919905419     PISSN: 09592989     EISSN: 18783619     Source Type: Journal    
DOI: 10.3233/BME-141229     Document Type: Conference Paper

References (29)

1. M.H. Criqui, Peripheral arterial disease-epidemiological aspects, Vasc. Med. 6(Suppl.) (2001), 3-7.
2. J.A. Mund, D.E. Ingram, M.C. Yoder and J. Case, Endothelial progenitor cells and cardiovascular cell-bases therapies, Cytotherapy 11 (2009), 103-113.
3. W. Schaper and I. Buschmann, Collateral circulation and diabetes, Circulation 99 (1999), 2224-2226.
4. M. Arras, W.D. Ito, D. Scholz et al., Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb, J. Clin. Invest. 101 (1998), 40-50.
5. M. Heil, T. Ziegelhoeffer, F. Pipp et al., Blood monocyte concentration is critical for enhancement of collateral artery growth, Am. J. Physiol. Heart. Circ. Physiol. 283 (2002), H2411-H2419.
6. C.E. Bergmann, I.E. Hoefer, B. Meder et al., Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice, J. Leukoc. Biol. 80 (2006), 59-65.
7. S. Shintani, T. Murohara, H. Ikeda et al., Mobilization of endothelial progenitor cells in patients with acute myocardial infarction, Circulation 103 (2001), 2776-2779.
8. T. Takahashi, C. Kalka, H. Masuda et al., Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization, Nat. Med. 4 (1999), 434-438.
9. T. Asahara, T. Takahashi, H.Masuda et al., VEGF contributes to postnatal neovascularization by mobilizing bone marrowderived endothelial progenitor cells, EMBO J. 15 (1999), 3964-3972.
10. E. Tateishi-Yuyama, H.Matsubara, T.Murohara et al., Therapeutic Angiogenesis using Cell Transplantation (TACT) study investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial, Lancet 10 (2002), 427-435.
11. T. Ziegelhoeffer, B. Fernandez, S. Kostin et al., Bone marrow-derived cells do not incorporate into the adult growing vasculature, Circ. Res. 6 (2004), 230-238.
12. J.L. Unthank, K.M. Sheridan and M.C. Dalsing, Collateral growth in the peripheral circulation: a review, Vasc. Endovascular. Surg. 4 (2004), 291-313.
13. B. Amann, C. Lüdemann, R. Ratei et al., Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia, Zentralbl. Chir. 4 (2009), 298-304.
14. M. Miyamoto, M. Yasutake, H. Takano, H. Takagi et al., Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy, Cell Transplant. 4 (2004), 429-437.
15. A.K. Das, B.J. Bin Abdullah, S.S. Dhillon et al., Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study, World J. Surg. 37 (2013), 915-922.
16. T. Bartsch, M. Brehm, T. Zeus et al., Transplantation of autologous mononuclear bone marrow stem cells in patients with peripheral arterial disease (the TAM-PAD study), Clin. Res. Cardiol. 96 (2007), 891-899.
17. R. Kolvenbach, C. Kreissig, C. Cagiannos et al., Intraoperative adjunctive stem cell treatment in patients with critical limb ischemia using a novel point-of-care device, Ann. Vasc. Surg. 24 (2010), 367-372.
18. P.M. Humpert, U. Bärtsch, I. Konrade et al., Locally applied mononuclear bone marrow cells restore angiogenesis and promote wound healing in a type 2 diabetic patient, Exp. Clin. Endocrinol. Diabetes 113 (2005), 538-540.
19. A.K. Das, B.J. Bin Abdullah, S.S. Dhillon et al., Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study, World J. Surg. 37 (2013), 915-922.
20. S.S. Yang, N.R. Kim, K.B. Park et al., A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease, Int. J. Stem. Cells 6 (2013), 37-44.
21. S.N. Dash, N.R. Dash, B. Guru et al., Towards reaching the target: clinical application of mesenchymal stem cells for diabetic foot ulcers, Rejuvenation Res. 17 (2014), 40-53.
22. P.K. Gupta, A. Chullikana, R. Parakh et al., A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia, J. Transl. Med. 10(11) (2013), 143.
23. D. Lu, B. Chen, Z. Liang et al., Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial, Diabetes Res. Clin. Pract. 92 (2011), 26-36.
24. J. Yan, G. Tie, T.Y. Xu et al., Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy, Stem. Cell. Rev. 9 (2013), 360-372.
25. T. Daikeler, I. Kötter, C. Bocelli Tyndall et al., Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature, Ann. Rheum. Dis. 66 (2007), 202-207.
26. I. Kötter, T. Daikeler, C. Amberger et al., Autologous stem cell transplantation of treatment-resistant systemic vasculitis-a single center experience and review of the literature, Clin. Nephrol. 64 (2005), 485-489.
27. J.C. Voltarelli, M.C. Oliveira, A.B. Stracieri et al., Haematopoietic stem cell transplantation for refractory Takayasu's arteritis, Rheumatology 43 (2004), 1308-1309.
28. J.M. Hare, J.H. Traverse, T.D. Henry et al., Randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction, J. Am. Coll. Cardiol. 54 (2009), 2277-2286.
29. C. Heeschen, R. Lehmann and J. Honold, Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease, Circulation 109 (2004), 1615-1622.